Los Angeles Capital Management LLC Enzo Biochem Inc Transaction History

Los Angeles Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.86 - $3.61 $686,422 - $866,428	-240,008 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$2.61 - $4.08 $6,316 - $9,873	-2,420 Reduced 1.0%	240,008 $825,000
Q4 2020 Feb 04, 2021	SELL	$1.82 - $2.61 $19,474 - $27,927	-10,700 Reduced 4.23%	242,428 $611,000
Q3 2020 Nov 02, 2020	BUY	$2.02 - $3.02 $23,539 - $35,192	11,653 Added 4.83%	253,128 $534,000
Q2 2020 Aug 05, 2020	BUY	$2.12 - $3.22 $511,927 - $777,549	241,475 New	241,475 $540,000
Q4 2019 Feb 07, 2020	SELL	$2.57 - $3.68 $25,915 - $37,109	-10,084 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$2.79 - $4.31 $210,474 - $325,142	-75,439 Reduced 88.21%	10,084 $34,000
Q1 2019 Apr 25, 2019	SELL	$2.54 - $4.02 $52,984 - $83,857	-20,860 Reduced 19.61%	85,523 $233,000
Q4 2018 Feb 11, 2019	SELL	$2.46 - $4.2 $2,706 - $4,620	-1,100 Reduced 1.02%	106,383 $296,000
Q3 2018 Nov 05, 2018	BUY	$3.81 - $5.53 $115,709 - $167,946	30,370 Added 39.38%	107,483 $443,000
Q2 2018 Jul 31, 2018	BUY	$5.06 - $6.78 $390,191 - $522,826	77,113 New	77,113 $400,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $47.7M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.